Navigation Links
Taking Statins Faithfully Lengthens Life
Date:2/9/2009

But experts note finding colored by fact that these folks take better care of themselves generally

MONDAY, Feb. 9 (HealthDay News) -- A massive Israeli study finds that people with high cholesterol levels who faithfully take statins are less likely to die over four to five years than those who neglect the therapy.

But that finding is not necessarily a tribute to the effectiveness of the cholesterol-lowering therapy, American experts said. Previous studies have shown that people who follow doctors orders about taking drugs are more likely to follow other rules of good health, they said.

The Israeli study of almost 230,000 middle-aged people enrolled in a health maintenance organization found a 45 percent lower death rate among those who took the drugs at least 90 percent of the time, compared to those taking the statins less than 10 percent of the time, according to a report in the Feb. 9 issue of the Archives of Internal Medicine by researchers at Maccabi Healthcare Services in Tel Aviv.

The risk reduction was true for both people who were prescribed a statin for secondary prevention, because they already had heart disease, and for primary prevention, to reduce the chance of having a first coronary event.

"The observed benefits from statins were greater than expected from randomized clinical trials, emphasizing the importance of promoting statin therapy and increasing its continuation over time for both primary and secondary prevention," the researchers wrote.

But it's not necessarily the statins that were responsible for all of the benefit, said Dr. Mark A. Hlatky, a professor of health research policy and medicine at Stanford University. He cited the Coronary Drug Project, done more than three decades ago, which showed an apparent benefit from faithfully taking a placebo.

"People who took placebo did much better than people who didn't take placebo," Hlatky said. They also did just about as well as people who took active drugs in the study.

For example, the five-year death rate for study participants who took the lipid-lowering drug clofibrate at least 80 percent of the time was 15 percent, compared to 24.6 percent of those who didn't follow orders.

But the numbers were virtually identical for those taking what they didn't know was a placebo -- a 15.1 percent mortality rate for those following the rules about taking the pill regularly, 28.3 percent for those not taking the pills as recommended, Hlatky said.

"It is definitely a very important observation that people who take their drugs always do better than people who don't, even if the drug is not terribly effective, because they tend to take better care of themselves better in a lot of ways," Hlatky said.

"While guidelines support the use of lipid-lowering medication in people with diabetes and other risk factors for coronary heart disease, they fall short in stipulating which class of lipid-lowering medication to use," said Dr. Erica Spatz, a fellow in the Robert Wood Johnson Clinical Scholars Program at Yale University.

More information

Statins and other cholesterol-lowering drugs are described by the American Heart Association.



SOURCES: Mark A. Hlatky, M.D., professor, health research policy and medicine, Stanford University, Stanford, Calif.; Erica Spatz, M.D., fellow, Robert Wood Johnson Clinical Scholars Program, Yale University, New Haven, Conn.; Feb. 9, 2009, Archives of Internal Medicine


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Depression Taking Toll on Returning U.S. Vets
2. 13 percent of women stop taking breast cancer drug because of side effects, U-M study finds
3. Study finds drug spending caps cause some seniors to quit taking key medicines
4. The Nutrition-Conscious Are Taking a Bite Out of Fast Food
5. New Resource for Taking Care of Aging Parents Available in Beta
6. Study finds drug spending caps cause some seniors to quit taking key medicines
7. Blue Cross And Blue Shield Association Survey Shows Consumer Driven Health Plan Enrollees Are Taking More Control of Their Healthcare
8. Taking the stress out of choosing the right stress test
9. Better Prostate Cancer Survival for Men Taking Statins
10. Multi-talented Entertainer Chris Brown Goes Back to School, Taking on a Starring Role in the St. Jude Math-A-Thon (R) Video
11. Mayo Clinic study finds that after heart attack most patients stop taking life-saving drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Taking Statins Faithfully Lengthens Life
(Date:10/13/2017)... ... 13, 2017 , ... The International Association of Eating Disorders ... for the field of eating disorders, announces the opening of early registration for ... Florida at the Omni Resort at ChampionsGate. , The annual iaedp™ ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... San Francisco, CA (PRWEB) , ... October 12, ... ... and Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus ... sleep apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... Oct. 2, 2017 Halo Labs announces the European launch ... called the HORIZON at MIBio 2017 in Cambridge, U.K ... visible particulate matter in biopharmaceutical samples with unprecedented speed and sensitivity ... novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
Breaking Medicine Technology: